Deepak A. Kapoor, MD, FACS, Author at Grand Rounds in Urology

Deepak A. Kapoor, MD, FACS

Integrated Medical Professionals

Farmingdale, New York

Deepak A. Kapoor, MD, is Chairman and CEO of Integrated Medical Professionals, PLLC (IMP), and Clinical Professor of Urology at the Icahn School of Medicine at Mount Sinai. Under his leadership, IMP has grown to the largest practice of its kind in the US, and is regarded as a national leader in quality management, utilization review, compliance processes, and the development of coordinated clinical pathways. Dr. Kapoor is President of Advanced Urology Centers of New York, Chairman of Health Policy and Past President of LUGPA, Chairman of SCRUBS RRG, a Director and Chairman of the Finance Committee of Allied Urological Services, and Founder and Past-President of the Integrated Medical Foundation. He has also served as a Director of UroPAC. Dr. Kapoor is a Fellow of the American College of Physician Executives and has published and lectured extensively on clinical and business medical issues. He is the 2014 recipient of the Russell W. Lavengood Distinguished Service Award, as well as the 2011 Ambrose-Reed Socioeconomic Essay Award. In addition to his administrative responsibilities, Dr. Kapoor continues an active clinical practice and is consistently ranked as a Top Doctor in New York.

Disclosures:

Talks by Deepak A. Kapoor, MD, FACS

Financial Toxicity: The New Driver of Healthcare Policy?

Posted by Deepak A. Kapoor, MD, FACS | Jul 2023

Deepak A. Kapoor, MD, FACS, discusses the issue of financial toxicity in healthcare, which he believes will shape health policy. He highlights the rising healthcare costs in the United States compared to other OECD countries, emphasizing the increasing burden shifted onto patients. This shift is primarily driven by the formation of healthcare exchanges, leading to higher deductibles, co-payments, and changing insurance plans.

Kapoor reveals that urological tumors account for a significant portion of cancer spending in the United States, exceeding $200 billion annually. Cancer care, in general, poses a profound economic burden, with patients depleting their savings, reducing retirement funds, and delaying medical care due to costs. Disturbingly, one in four cancer patients lose their homes within five years of diagnosis.

Dr. Kapoor emphasizes the disproportionate impact of this economic burden on marginalized populations, including single mothers, low-income individuals, and historically marginalized groups like Blacks and Hispanics. Dr. Kapoor provides an example of how a simple referral to a hospital-based imaging facility can result in significantly higher costs compared to a radiology facility in a community setting.

2019 Economic Outlook for Urology in the United States

Posted by Deepak A. Kapoor, MD, FACS | May 2019

Deepak A. Kapoor, MD, FACS, discusses the history of efforts in the United States to transition healthcare toward a structure of value-based care. He then outlines major 2019 regulatory initiatives and how they will impact healthcare payments and the administrative burden for urologists.